Mark J. Enyedy, CHIEF EXECUTIVE OFFICER at ImmunoGen, Inc. (IMGN), sold 40,214 shares at $29.28 ($1.2M) on 2024-02-05, disclosed to the SEC on 2024-02-06.
Scheduled sale ($1.2M) by CHIEF EXECUTIVE OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.28 | 20,107 | $589K | 50.0% |
| 2 | $29.28 | 20,107 | $589K | 50.0% |
| Total | $29.28 avg | 40,214 | $1.2M | 100% |
| Filing → |
| IMGN | SELL | 2019-02-25 | $286K | — | Filing → |
| IMGN | SELL | 2018-02-23 | $1.5M | — | Filing → |
| IMGN | BUY | 2016-11-09 | $46K | — | Filing → |